GridAI Technologies Corp. (GRDX) vs IGC Pharma, Inc. (IGC)

GridAI Technologies Corp. and IGC Pharma, Inc. are both Biotechnology companies. GridAI Technologies Corp. and IGC Pharma, Inc. are of similar size ($29.1M and $27.2M). GridAI Technologies Corp. has the higher net margin (0.00% vs −795.5%) and the higher return on invested capital (−79.3% vs −91.5%). Across the 14 metrics below, GridAI Technologies Corp. leads on 8 and IGC Pharma, Inc. on 6.

Valuation

Metric GRDX IGC Biotechnology median
P/E n/m n/m 7.88
P/S n/m 25.52 11.47
P/B 1.55 4.58 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 26.18 10.73
Earnings yield (164.82%) (32.14%) (28.84%)
Free cash flow yield (35.05%) (20.24%) (23.03%)

Profitability

Metric GRDX IGC Biotechnology median
Gross margin 0.00% 32.33% 65.16%
Operating margin 0.00% (912.44%) 0.00%
Net margin 0.00% (795.46%) 0.00%
Free cash flow margin 0.00% (516.53%) 0.00%
Return on equity (485.89%) (143.46%) (57.72%)
Return on assets (34.14%) (100.44%) (49.22%)
Return on invested capital (79.29%) (91.53%) 0.00%

Growth

Metric GRDX IGC Biotechnology median
Revenue growth (TTM) — (13.38%) 5.64%
EPS growth (last fiscal year) 74.65% 57.85% —
Revenue growth, 5-year CAGR — (20.77%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GRDX IGC Biotechnology median
Debt to equity 0.01 0.18 0.00
Current ratio 0.16 0.39 4.73
Net debt to EBITDA 0.10 0.04 0.96

Dividend

Metric GRDX IGC Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GRDX IGC Biotechnology median
Market cap 27.17m 29.11m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack